Viewing Study NCT02576912


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-01-11 @ 3:25 PM
Study NCT ID: NCT02576912
Status: COMPLETED
Last Update Posted: 2023-08-07
First Post: 2015-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone
Sponsor: Yale University
Organization:

Study Overview

Official Title: Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: THC-Preg
Brief Summary: The overall purpose of this study is to examine the effect of pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG and then assessing their responses to THC.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: